Literature DB >> 465294

Side-effects of mixed agonist-antagonist analgesics used in sequential anaesthesia.

C Devaux, P Schoepffler, J P Gauthier-Lafaye.   

Abstract

1 Mixed agonist-antagonist analgesics have analgesic action but also possess a range of side-effects. 2 Narcotic antagonists do not reverse the non-specific effects of opiates. 3 Under certain circumstances the effects of agonists and mixed agonist-antagonists can be additive. 4 Chronic dosage of mixed agonist-antagonists leads to a lower level of dependence than that observed with the standard narcotics. 5 Mixed agonist-antagonists may not antagonize the respiratory effects of narcotics and may result in potentiation of such depression.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 465294      PMCID: PMC1429303          DOI: 10.1111/j.1365-2125.1979.tb04708.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  5 in total

1.  Animal and molecular pharmacology of mixed agonist-antagonist analgesic drugs.

Authors:  M J Rance
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

2.  Respiratory and circulatory effects of intravenous butorphanol and morphine.

Authors:  H Nagashima; A Karamanian; R Malovany; P Radnay; M Ang; S Koerner; F F Foldes
Journal:  Clin Pharmacol Ther       Date:  1976-06       Impact factor: 6.875

Review 3.  Butorphanol: a review of its pharmacological properties and therapeutic efficacy.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-12       Impact factor: 9.546

4.  Pharmacological and clinical importance of narcotic antagonists and mixed antagonists--use in cardiology.

Authors:  D J Coltart; A D Malcolm
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

5.  A double blind comparison of buprenorphine and morphine in conscious subjects following administration by the intramuscular route.

Authors:  J M Orwin; J Orwin; M Price
Journal:  Acta Anaesthesiol Belg       Date:  1976
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.